Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Subcutaneous IL-2 boosts CD4 cell counts in HIV-infected patients

March 26, 1997

Sankyo reveals natural alpha-glucosidase inhibitor

March 25, 1997

Vitrasert receives European marketing clearance

March 24, 1997

Collaborative effort culminates in clinical trials for HIV gene therapy using ribozymes

March 20, 1997

Phase II/III results for i.v. cidofovir in CMV retinitis

March 18, 1997

FDA approves Viracept for adult and pediatric use

March 17, 1997

Ritonavir approved for pediatric use in U.S.

March 17, 1997

Advanced Viral Research and the NCI sign genetic research agreement

March 14, 1997

Water-soluble HIV protease inhibitor from Sankyo

March 14, 1997

AIDS progression and link to chemokine receptors

March 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...